The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtome Plc Regulatory News (ATOM)

Share Price Information for Atome Plc (ATOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.00
Bid: 55.00
Ask: 57.00
Change: -0.50 (-0.88%)
Spread: 2.00 (3.636%)
Open: 56.50
High: 56.50
Low: 56.00
Prev. Close: 56.50
ATOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

28 Sep 2023 07:00

RNS Number : 9150N
ATOME Energy PLC
28 September 2023
 

28 September 2023

ATOME ENERGY PLC

("ATOME", "the Company", or "the Group")

 

Unaudited Results for the Six Months Ended 30 June 2023

Current Trading Update

 

ATOME Energy (AIM: ATOM), the only international green hydrogen, ammonia and fertiliser project development company on the London Stock Exchange, with large-scale projects of over 600MW in South America and Europe concentrating on energy and food security, together with hydrogen mobility projects, is pleased to announce its unaudited results for the six-month period ended 30 June 2023 which are set out below together with a current trading update.

 

H1 2023 Highlights:

 

- ATOME recorded a loss for the six months ended 30 June 2023 of US$2.9 million (US$ 2.5 million for six months ended 30 June 2022 and US$5.6 million year ended 31 December 2022), with US$2.1 million of costs capitalised in relation to Villeta project FEED studies, as these activities are directly related to design and construction of the project currently proceeding on a fast track to EPC contract and a Final Investment Decision ("FID") in Q4 2023.

- In January 2023, ATOME signed a mandate with IDB Invest, the private-sector arm of the multilateral Inter-American Development Bank, which has agreed to provide certain grant funding towards the costs of the Environmental and Social Impact Assessment ("ESIA"), with the ESIA being a key step towards project development and positively contributing towards decision making by all funders before FID.

- In May 2023, the Company completed a successful placing of shares to Baker Hughes and other institutional shareholders totalling US$4.6 million and announced the extension of its Villeta project to production of green fertiliser, aiming to serve the significant and growing agricultural market in South America and worldwide.

- In July 2023, ATOME increased its 120-megawatt ("MW") power purchase agreement ("PPA") at Phase I Villeta Project to 145MW and entered a 300MW pre-PPA agreement for Phase II Yguazu Project with commencement of necessary studies, increasing total committed power supply in Paraguay to 445MW. ATOME also obtained an approval in relation to its application for tax-free zone status at Villeta Project conditional on completion of environmental studies.

- Since announcing its move to green fertiliser production, ATOME has received multiple written expressions of interest from leading international players for the whole of the offtake of Phase I production, which aims to potentially displace up to 500,000 tons of CO2eq per year.

- Investment Memorandum for Villeta project in Paraguay was circulated to selected potential project-level equity and debt investors in August 2023 and an FID for Phase I Villeta is currently expected in Q4 2023.

 

Current Trading Update

 

ATOME continues to make progress on its projects, with Paraguay in particular running ahead of the expected goals set by the Directors.

 

The Company has developed into a world leading green fertiliser project development company benefiting from the unique position of Paraguay having an excess of competitively priced available baseload low-cost plug and play green electricity from the grid and being located at the centre of the South American agricultural market, which is the largest fertiliser import market in the world.

 

Phase 1 of Villeta is on track to achieve FID by the end of 2023, with construction activities commencing immediately thereafter and a significantly expanded green fertiliser project coming on stream by the end of 2025.

 

During the first six months of 2023 and to the date of this report, ATOME has been able to achieve further significant progress in developing its projects, as well as creating a joint venture with its partners in Costa Rica through National Ammonia Corporation ("NAC").

 

The Company views the future with increasing confidence as it focuses on maintaining the momentum shown since IPO and continues to seek to expand the current portfolio of interests.

 

Statement by Peter Levine, Chairman and Olivier Mussat, CEO

 

ATOME's results for the six months ended 30 June 2023 reflect commendable progress for the Company.

 

The Villeta project alone will be the largest green fertiliser production facility in the world when it comes on stream at the end of 2025 and has the capability of serving domestic and South American as well as European and Asian markets, benefiting from soon to be granted Tax Free Zone status. The Second Phase, code named Iguazu with power already reserved, is nearly triple the size and capacity of Villeta and could be completed within 24 months of Viletta project commissioning.

 

The FEED packages for Villeta are nearing completion and negotiations for awarding the EPC contract are at an advanced stage, working with the internationally renowned engineers Aecom as our Owner's Engineer.

 

The finance process for Villeta has been launched by our advisers Natixis, with the multi-lateral IDB Invest mandate already signed, which has already generated significant positive interest both on a debt and equity level internationally as well as locally. In-country visits and face-to-face presentations have already commenced.

 

As sustainability and climate concerns are now impacting the food and agricultural sectors, with carbon tariffs on fertiliser imports being implemented in the EU from 2026, we have expanded our move into Central America with our joint venture vehicle NAC, in Costa Rica where we have a very prospective 100MW project. This is almost a cut and paste of Villeta in a country which has 98% renewable power. At the same time, we have increased our own management expertise including the appointment of Terje Bakken formerly of Yara and Eurochem as Commercial Head. Iceland remains in our portfolio as one for the future.

 

This second half of the year is an exciting time for our project progression, and we look forward to delivering further positive news as we progress towards FID on our first project. We view the outlook for ATOME with significant confidence.

 

The 2023 Half Year Report and Financial Statements will be made available at https://www.atomeplc.com/

 

 

For more information, please visit https://www.atomeplc.com or contact:

 

ATOME Energy PLC Nikita Levine, Investor Relations

+44 (0) 113 337 2210info@atomeplc.com

Beaumont Cornish (Nominated Adviser) Roland Cornish, Michael Cornish

+44 (0) 20 7628 3396

Liberum (Joint Broker) Scott Mathieson, Kane Collings

+44 (0) 20 3100 2000

SP Angel (Joint Broker) Richard Hail, Harry Davies-Ball

+44 (0) 20 3490 0470

Cavendish Capital Markets Limited (Broker) Simon Hicks, George Dollemore

+44 (0) 20 7220 0500

Tavistock (Financial PR and IR) Simon Hudson, Rebecca Hislaire, Charles Baister

+44 (0) 20 7920 3150 atome@tavistock.co.uk

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon publication of this announcement, this inside information is now considered to be in the public domain. The person who arranged for the release of this announcement on behalf of the Company was Peter Levine, Chairman.

 

About ATOME

 

ATOME Energy PLC is an AIM listed company targeting green hydrogen, ammonia, and fertiliser production with over 600-megawatt of projects in Paraguay, Iceland, and Central America.

 

Since its admission to AIM in December 2021 ATOME has signed its first electrolyser purchase order for its hydrogen transport Mobility Division due to start generating revenue in 2023 and signed a 145MW power purchase agreement with ANDE, the state energy company in Paraguay for production of green ammonia to produce industrial scale premium value green fertiliser in 2025. It has procured 30 hectares of land in Villeta, Paraguay for that facility, mandated Natixis Corporate & Investment Banking and the multilateral IDB Invest to lead the project funding and with Front End Engineering and Design studies currently underway with the international companies Urbas and Casale.

 

In December 2022, ATOME entered into a joint venture with Cavendish, the renewable energy arm of the substantial and well-established Purdy Group based in Costa Rica and formed The National Ammonia Corporation S.A, which is owned equally by ATOME and Cavendish.

 

ATOME is in the process of operational planning, sourcing and negotiations with green electricity suppliers, equipment providers and offtake partners, including signed memoranda of understanding and cooperation agreements in place with key parties, to produce green ammonia at an industrial scale using electricity generated from existing geothermal sources in Iceland and hydroelectric power in Paraguay and Costa Rica. All chosen sites are located close to the power and water sources and export facilities to serve significant domestic and then international demand.

 

The Company has a green-focused Board which is supported by major shareholders including Peter Levine, Trafigura, one of the world's leading commodity and logistics company, and Schroders, a leading fund manager, and since May 2023, Baker Hughes, a global energy technology company operating in the energy and industry sectors.

 

 

 

Financial Review to 30 June 2023

 

The condensed financial statements present the half-year results for the six months ended 30 June 2023 for ATOME Energy PLC, a green hydrogen, ammonia and fertiliser project development company on the London Stock Exchange, with large-scale projects of over 600MW in South America and Europe concentrating on energy and food security, together with hydrogen mobility projects.

 

Operating loss attributable to the Group's equity holders was in line with expectations and totalled US$ 2.9 million (US$2.5 million for the six months ended 30 June 2022). As Villeta project has advanced with front end engineering and design (FEED), costs incurred on the FEED contract and other directly attributable costs totalling US$2.1 million were capitalised in the six months ended 30 June 2023.

 

Net cash used by operating activities totalled US$3.3 million (US$3.7 million for the six months ended 30 June 2022 and US$6.2 million for the year ended 31 December 2022, respectively), with cash used by investing activities totalling US$2.1 million.

 

Operating deficit and investing activities cash outflows were financed primarily by the receipt of net proceeds received from the issue of shares in the placing totalling US$4.6 million (US$3.7 million in six months ended 30 June 2022 and US$7.9 million in the year ended 31 December 2022).

 

Additional financial support is available to the Group in the form of an Unconditional Standby Equity Facility Agreement whereby Peter Levine, Chairman and one of his investment vehicles, PLLG Investments Limited, have agreed to subscribe for shares at the placing price of 80p per share at the call option of the Company at no cost and at any time during the period to end June 2024. This provides an additional £3.0 million facility to the Group should it so require after considering other forms of financing available.

 

The results of the Group are presented in US Dollars as all its budgeting, cost management and future trading is or will be denominated in US Dollars. The foreign exchange gains and losses arising from translation from the Group entities functional currency to US Dollars are taken to the Translation reserve on the statement of financial position.

 

6 months

6 months

Period to

to 30 June

to 30 June

31 Dec

2023

2022

2022

(Unaudited)

(Unaudited)

(Audited)

US$000

US$000

US$000

Income from grants

6

31

170

Other Income

-

-

62

Loss before tax

(2,856)

(2,501)

(5,598)

Net cash from operating activities

(3,257)

(3,710)

(6,152)

Net cash from investing activities

(2,070)

(14)

-

Proceeds from issue of shares (net of expenses)

4,583

3,689

7,965

Net cash/(debt)

2,838

1,633

3,452

Cash balance

3,634

1,633

3,452

 

 

 

 

 

Condensed Consolidated Statement of Comprehensive Income

 

6 months

6 months

Period to

to 30 June

to 30 June

31-Dec

2023

2022

2022

(Unaudited)

(Unaudited)

(Audited)

Note

US$000

US$000

US$000

Administrative expenses

3

 (2,870)

 (2,531)

 (5,830)

Other Income

 -

 -

 62

Investment grant

 6

 31

 170

Operating loss

 

 (2,864)

 

 (2,500)

 

 (5,598)

 

Finance Income

22

 -

 2

Finance costs

 (37)

 (1)

 (2)

Foreign exchange gain (loss)

 23

 -

 -

Loss before taxation

 

 (2,856)

 

 (2,501)

 

 (5,598)

 

Income tax (charge)/credit

 

Current tax income tax (charge)/credit

 -

 -

 -

Deferred tax being a provision for future taxes

 -

 -

 -

Total income tax (charge)/credit

 -

 -

 -

Loss for the period from continuing operations

 

 (2,856)

 

 (2,501)

 

 (5,598)

Non-controlling interest share of the comprehensive loss

 42

 66

 119

Loss attributable to the equity holders

 

 (2,814)

 

 (2,435)

 

 (5,479)

 

Other comprehensive income (loss)

 

Items that may be reclassified subsequently to profit or loss

 256

 (413)

 (387)

Total comprehensive profit/(loss) for the period

 

attributable to the equity holders of the Parent Company

 

 (2,558)

 

 (2,848)

 

 (11,345)

 

Earnings/ (loss) per share from continuing operations

 

US cents

US cents

US cents 

Basic earnings/ (loss) per share

4

 (7.71)

 (7.70)

 (16.80)

Diluted earnings / (loss) per share

4

 (7.71)

 (7.70)

 (16.80)

 

 

 

 

Condensed Consolidated Statement of Financial Position

 

30-Jun

30-Jun

31-Dec

2023

2022

2022

(Unaudited)

(Unaudited)

(Audited)

US$000

US$000

US$000

Note

ASSETS

Non-current assets

Goodwill

 6

 7

 6

Property, plant and equipment

5

 3,059

 46

 939

 3,065

 

53

 

945

Current assets

Trade and other receivables

6

 2,842

 1,915

 2,223

Cash and cash equivalents

 3,634

 1,633

 3,452

 6,476

 

 3,548

 

 5,675

TOTAL ASSETS

 9,541

 

 3,601

 

 6,620

LIABILITIES

Current liabilities

Trade and other payables

7

 1,197

 296

 1,649

Short-term facility

 -

 -

 -

 1,197

 

 296

 

 1,649

Non-current liabilities

Long Term Debt

 796

Trade and other payables

7

 -

 10

 -

 796

 

 10

 

 -

TOTAL LIABILITIES

 1,993

 

 306

 

 1,649

EQUITY

Share capital

 106

 87

 96

Share premium

 16,786

 7,653

 11,901

Translation reserve

 (75)

 (369)

 (331)

Profit and loss account

 (10,536)

 (4,666)

 (7,722)

Share base payment reserve

 1,428

 656

 1,146

Equity attributable to owners of the parent

 7,709

 

 3,361

 

 5,090

Non-controlling interest

 (161)

 (66)

 (119)

TOTAL EQUITY

 7,548

 

 3,295

 

 4,971

TOTAL EQUITY AND LIABILITIES

 9,541

 

 3,601

 

 6,620

 

 

 

Condensed Consolidated Statement of Changes in Equity

Share capital and premium

Profit & loss account

Other Reserves

Total

Non-controlling interest

Total

US$000

US$000

US$000

US$000

US$000

US$000

Balance as at 1 January 2022

 

 7,740

 (2,243)

 139

 5,636

 -

 5,636

 

Share-based payments

 -

 -

 573

 573

 -

 573

Transactions with owners

 

 -

 -

 573

 573

 -

 573

 

Loss for the period

 -

 (2,501)

 -

 (2,501)

 -

 (2,501)

Non-controlling interest share in comprehensive loss

 66

 -

 66

 (66)

 -

Exchange differences on

translation

 12

 (425)

 (413)

 -

 (413)

Total comprehensive loss

 

 -

 (2,423)

 (425)

 (2,848)

 (66)

 (2,914)

Balance as at 30 June 2022

 

 7,740

 (4,666)

 287

 3,361

 (66)

 3,295

Share-based payments

 -

 -

 490

 490

 -

 490

Offer of shares to public

 4,394

 -

 -

 4,394

 -

 4,394

Costs of issue new shares

 (137)

 -

 -

 (137)

 -

 (137)

Transactions with owners

 

 11,997

 (4,666)

 777

 8,108

 (66)

 8,042

Loss for the period

 -

 (3,109)

 -

 (3,109)

 -

 (3,109)

Non-controlling interest share in comprehensive loss

 53

 53

 (53)

 -

Exchange differences on

translation

 -

 38

 38

 38

Total comprehensive

 

income/(loss)

 

 -

 (3,056)

 38

 (3,018)

 (53)

 (3,071)

Balance as at 1 January 2023

 

 11,997

 (7,722)

 815

 5,090

 (119)

 4,971

Share-based payments

 -

 -

 282

 282

 -

 282

Offer of shares to public

 5,086

 -

 -

 5,086

 -

 5,086

Costs of issue new shares

 (191)

 -

 -

 (191)

 -

 (191)

Transactions with owners

 

 4,895

 -

 282

 5,177

 -

 5,177

Loss for the period

 -

 (2,856)

 -

 (2,856)

 -

 (2,856)

Non-controlling interest share in comprehensive loss

 42

 -

 42

 (42)

 -

Exchange differences on

translation

 -

 256

 256

 -

 256

Total comprehensive income/(loss)

 

 -

 (2,814)

 256

 (2,558)

 (42)

 (2,600)

Balance as at 30 June 2023

 

 16,892

(10,536)

 1,353

 7,709

 (161)

 7,548

 

 

 

 

Condensed Consolidated Statement of Cash Flows

Six months ended 30 June 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6 months

6 months

Period to

to 30 June

to 30 June

31-Dec

2023

2022

2022

(Unaudited)

(Unaudited)

(Audited)

US$000

US$000

US$000

Cash flows from operating activities - (Note 8)

Cash generated/(consumed) by operations

 (3,257)

 (3,710)

 (6,152)

 (3,257)

 

 (3,710)

 

 (6,152)

Cash flows from investing activities

 

Additions to property plant and equipment

 (2,070)

 (14)

 -

 (2,070)

 

 (14)

 

 -

Cash flows from financing activities

 

Proceeds from issue of shares (net of expenses)

 4,583

 3,689

 7,965

Loan drawdown

 796

 -

 -

Repayment of borrowings

 -

 -

 -

Repayment of obligations under leases

 (13)

 (12)

 (26)

 5,366

 

 3,677

 

 7,939

Net increase/(decrease) in cash and cash equivalents

 (39)

 (47)

 1,787

Opening cash and cash equivalents at beginning of year

 3,452

 1,865

 1,865

Exchange (losses)/gains on cash and cash equivalents

(143)

 (185)

 (200)

Closing cash and cash equivalents

 3,634

 

 1,633

 

 3,452

 

 

Notes to the Financial Statements

Six months ended 30 June 2023

 

1. Nature of operations and general information

ATOME Energy PLC (the Company) is a public company limited by shares and incorporated in England in the United Kingdom under the Companies Act 2006. The address of the Company's registered office is Carrwood Park, Selby Road, Leeds, LS15 4LG. The Company's and its subsidiaries' (the Group) operations and principal activities include planning, development and execution of the projects to produce green hydrogen, ammonia and fertiliser using renewable energy. The Company is quoted on the AIM market of the London Stock Exchange (ticker: ATOM), and is headquartered in Leeds, UK, with offices in Asunción, Paraguay and Akureyri, Iceland.

 

These condensed consolidated interim financial statements (the interim financial statements) have been approved for issue by the Board of Directors on 22 September 2023. The financial information for the year ended 31 December 2022 set out in this interim report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The financial information for the six months ended 30 June 2023 and 30 June 2022 was neither audited nor reviewed by the auditor. The Group's audited statutory financial statements for the year ended 31 December 2022 have been filed with the Registrar of Companies. The auditor's report on those financial statements was unqualified, did not include a reference to matters to which the auditors drew attention by way of emphasis except for potential material uncertainty that may arise in the event if, despite the Directors' stated confidence, the Company is unable to achieve project finance by December 2024, around the Company's ability to continue as a going concern, and did not contain a statement under section 498(2) or (3) of the Companies Act 2006.

 

2. Basis of preparation

The interim financial statements do not include all the information required for full annual financial statements and should be read in conjunction with the consolidated financial statements of the Group for the year ended 31 December 2022, which have been prepared in accordance with UK adopted International Accounting Standards.

 

These financial statements have been prepared under the historical cost convention, except for any derivative financial instruments which have been measured at fair value. The accounting policies adopted in the 2023 interim financial statements are the same as those adopted in the financial statements for the year ended 31 December 2022, as included in the 2022 Annual report.

 

6 months

6 months

Period to

to 30 June

to 30 June

31 Dec

2023

2022

2022

(Unaudited)

(Unaudited)

(Audited)

US$000

US$000

US$000

3 Administrative expenses

 

Directors' fees and related costs (including non-executive Directors)

 833

 717

 2,036

Staff costs

 576

 143

 910

Cost of issue for existing shares

 -

 -

 164

Share-based payments

 -

 573

 1,063

Depreciation

 -

 12

 24

Other

 1,461

 1,086

 1,633

 2,870

 2,531

 5,830

 

4 Earnings / (loss) per share

 

Net profit / (loss) for the period attributable

to the equity holders of the

Parent Company

 (2,856)

 (2,501)

 (5,598)

Number

Number

Number

'000

'000

'000

Weighted average number

of shares in issue

 37,019

 32,500

 32,606

Earnings /(loss) per share

US cents

US cents

US cents

Basic

 (7.71)

 (7.70)

 (16.80)

Diluted

 (7.71)

 (7.70)

 (16.80)

 

5 Property, plant and equipment

 

Land

Leased

Asset

Total

Assets

Assets

Under Construction

US$000

US$000

US$000

US$000

Cost

 

At 1 January 2022

 -

 47

 47

Additions

 -

 -

 -

At 30 June 2022

 -

 47

 -

 47

Additions

 918

 -

 918

At 1 January 2023

 918

 47

 -

 47

Additions

 -

 -

 2,132

 2,132

At 30 June 2023

 918

 47

 2,132

 3,097

Depreciation/Impairment

 

At 1 January 2022

 -

 2

 2

Charge for the period

 -

 12

 12

At 30 June 2022

 -

 14

 -

 14

Charge for the period

 -

 12

 12

At 1 January 2023

 -

 26

 -

 26

Charge for the period

 12

 12

At 30 June 2023

 -

 38

 -

 38

Net Book Value 30 June 2023

 

 918

 

 9

 

 2,132

 

 3,059

Net Book Value 30 June 2022

 

 -

 

 33

 

 -

 

 33

Net Book Value 31 December 2022

 918

 

 21

 

 -

 

 939

 

 

 

6 months

6 months

Period to

to 30 June

to 30 June

31 Dec

2023

2022

2022

(Unaudited)

(Unaudited)

(Audited)

US$000

US$000

US$000

6 Trade and other receivables

 

Outstanding on share issue

 2,037

 1,279

 1,601

Prepayments

 421

 553

 268

Other receivables

 384

 83

 354

 2,842

 1,915

 2,223

7 Trade and other payables

 

Current

Other payables

 1,187

 272

 1,543

Costs of issue for new and existing shares outstanding

 -

 -

 84

Current portion of leases

 10

 24

 22

 1,197

 296

 1,649

Non-current

Long Term Debt

 796

 -

 -

Non-current portion of leases

-

 10

-

 796

 10

 -

Total carrying value

 1,993

 306

 1,649

 

 

 

8. Reconciliation of operating profit to net cash outflow from operating activities

 

 

 

6 months

6 months

Period to

to 30 June

to 30 June

31 Dec

2023

2022

2022

(Unaudited)

(Unaudited)

(Audited)

US$000

US$000

US$000

Profit/(loss) from operations before taxation

 

 (2,857)

 

 (2,501)

 

 (5,598)

Interest on Bank Deposits

 2

Depreciation and impairment of property,

plant and equipment

 12

 12

 24

Interest accretion on lease liability

 1

 1

-

Placing costs expensed

 191

 -

 -

Share-based payments

 282

 573

 1,063

Operating cash flows before movements in working capital

 

 (2,371)

 

 (1,915)

 

 (4,509)

 

(Increase)/decrease in receivables

 (439)

 (409)

 (394)

Increase/(decrease) in short-term facility

 -

 (1,412)

 (1,415)

(Decrease)/increase in payables

 (447)

 14

 369

Foreign exchange loss/(gain)

 -

 12

 (203)

Net cash generated by/(used in)

 

operating activities

 

 (3,257)

 

 (3,710)

 

 (6,152)

 

 

9. Capital commitments

The Group's outstanding capital commitments in relation to its projects totalled US$5.3 million as at 30 June 2023 and as at the date of this report, with US$2.8 million due within the next 12 months.

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR NKOBBDBKBFCB
Date   Source Headline
20th Mar 20249:00 amRNSFurther Subscription & TVR
14th Mar 20247:00 amRNSEIS investment status granted by HMRC
29th Feb 20249:41 amRNSTotal Voting Rights
27th Feb 202410:51 amRNSHolding(s) in Company
22nd Feb 20244:09 pmRNSDirector/PDMR Shareholding
21st Feb 20242:55 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSPlacing and Subscription raises £1.8 million
14th Feb 20247:00 amRNSSignificant progress on green fertiliser project
2nd Feb 20247:00 amRNSChange of Name to ATOME PLC
1st Feb 20247:00 amRNSProposed Change of Name to ATOME PLC
17th Jan 20247:00 amRNSUpdate on Paraguay Operations
30th Nov 202312:00 pmRNSDirector/PDMR Shareholding
29th Nov 202311:00 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSUpdate on Mobility Division
24th Nov 20237:00 amRNSDirector / PDMR Shareholding Transaction
14th Nov 20237:00 amRNSATOME granted Free-Trade Zone for Villeta Project
31st Oct 20237:00 amRNSUpdate on Paraguay Operations
28th Sep 20237:00 amRNSHalf-year Report
21st Sep 202312:14 pmRNSShares Investor Event
5th Sep 20237:00 amRNSExtended Investor Video and Investor Presentation
16th Aug 20237:00 amRNSDistribution of IM, Carbon Credits Identified
25th Jul 202312:43 pmRNSResult of AGM
25th Jul 20239:56 amRNSHolding(s) in Company
25th Jul 20239:55 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSSignificant Progress in Paraguay
14th Jul 20237:00 amRNSTransaction by Significant Shareholder
29th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
27th Jun 20237:00 amRNSAudited Results for the year ended 31 Dec 2022
2nd Jun 20237:00 amRNSTotal Voting Rights
23rd May 20232:40 pmRNSAdditional Issue of Shares
22nd May 20237:00 amRNSStrategy Update and Investment
4th May 20232:16 pmRNSAIM Rule 17 and Schedule 2(g) Disclosure
4th Apr 20237:00 amRNSIceland Update
20th Mar 20233:06 pmRNSDirector/PDMR Shareholding
17th Mar 20239:37 amRNSHolding(s) in Company
15th Mar 20232:02 pmRNSDirector/PDMR Shareholding
15th Mar 202311:31 amRNSHolding(s) in Company
15th Mar 202311:27 amRNSHolding(s) in Company
1st Mar 20239:00 amRNSInvestor Presentation
1st Mar 20237:41 amRNSDirector/PDMR Shareholding
13th Feb 20237:00 amRNSANDE Reports on London Visit
2nd Feb 20237:00 amRNSNew joint venture in Central America
30th Jan 20237:00 amRNSDirector for Ammonia and Fertiliser Market
11th Jan 20237:00 amRNSATOME signs finance mandate letter with IDB Invest
9th Jan 20237:00 amRNSATOME Paraguay Update
5th Jan 20237:00 amRNSDuel Fuel Joint Venture
21st Dec 20222:15 pmRNSHolding(s) in Company
21st Dec 20222:10 pmRNSHolding(s) in Company
20th Dec 20221:14 pmRNSHolding(s) in Company
19th Dec 202212:55 pmEQSAtome Energy in 'opportunistic' fundraise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.